Protein's essential role in repairing damaged cells revealed
January 07, 2009
ANN ARBOR, Mich. - University of Michigan researchers have discovered that a key protein in cells plays a critical role in not one, but two processes affecting the development of cancer.
"Most proteins involved in responding to DNA damage that can cause cancer either help detect the damage and warn the rest of the cell, or help repair the damage," says David O. Ferguson, M.D., Ph.D., the study's lead author. Ferguson is an assistant professor of pathology at the U-M Medical School and a member of U-M's Comprehensive Cancer Center.
Prior research has shown that the protein, Mre11, functioned as a "gatekeeper" to signal injury to the cell and prevent damaged cells from proliferating. Now, Ferguson and colleagues have discovered that in mammals, a function of the Mre11 protein also serves as a "caretaker," by repairing DNA.
Their findings, published in the journal Cell, could have important implications for cancer treatment by someday allowing oncologists to predict a tumor's sensitivity to radiation and other therapies, making it more vulnerable to treatment.
Under normal circumstances, the body's cells grow, divide and eventually die. When something damages a healthy cell's DNA -- such as radiation or exposure to a toxin -- a multiprotein complex steps in to repair the breakage and activate other fundamental cellular processes.
The MRN complex, comprised of the Mre11, Rad50 and NBS1 proteins, senses DNA damage, known as double-strand breaks, within the cell. The complex then transmits that information to an enzyme called the ATM (ataxia-telangiectasia mutated) checkpoint kinase.
The ATM kinase controls the cell's response to double-strand breaks, and slows cell growth to give the cell opportunities to repair them, says Ferguson.
When the MRN complex doesn't work properly, inherited human neurological diseases, such as ataxia-telangiectasia-like syndrome and Nijmegen breakage syndrome, result. Both feature MRN mutations and significantly predispose a person to immunodeficiency and cancer.
What Ferguson and colleagues discovered is that Mre11 not only senses and communicates damage, it also repairs DNA double-strand breaks by acting as a nuclease, an enzyme that modifies and processes the broken DNA ends.
Research details
The researchers generated mouse models to examine the exact role of Mre11 in the MRN complex. They engineered two mouse strains, one in which Mre11 was disabled completely, and one in which only a single amino acid change was made.
What surprised researchers the most was that making that change to a single amino acid in Mre11 caused consequences as severe as when they eliminated the entire MRN complex.
Taking out the amino acid in Mre11 responsible for nuclease activity caused the mice to develop growth defects, chromosomal abnormalities and sensitivity to DNA-damaging agents. Therefore, researchers could say that the nuclease, or repair, activity of Mre11 proves critical for both MRN function and stability of the genetic material of the organism.
"First, Mre11 signals to the cell by activating the kinase, but it also acts in the repair of double-strand breaks via the nuclease functions. Therefore, it prevents the two individual steps that lead to cancer," Ferguson says.
Implications
The work, called "virtuoso cell engineering" in a Cell preview article, holds particular promise for identifying mutations associated with many cancers.
"What's emerging in the literature from large-scale screening studies of human tumors is that Mre11 may be frequently mutated in certain cancers," Ferguson says.
"This may have implications for diagnoses because tumors associated with different mutations may have different prognoses and respond to different therapies," he says. In particular, mutations in Mre11 may predict how sensitive or resistant a particular tumor will be to treatments with DNA-damaging agents.
"The fact that we have now separated the functions of DNA repair from the checkpoint functions means we may have identified a target that can sensitize tumors to radiation and chemotherapeutic agents used in treating cancer."
Additional U-M authors are first author Jeffrey Buis, Yipin Wu, Jennifer Leddon, Gerwin Westfield, Mark Eckersdorff and JoAnn M. Sekiguchi.
Funding for the research came from the National Institutes of Health, the Sidney Kimmel Cancer Research Foundation and the University of Michigan Cancer Center Support Grant and Munn Endowment.
University of Michigan Health System
|
|
Nanocapsules target damaged cells. (Biotechnology News).(protect against radiation)(Brief Article): An article from: Nanoparticle News
by Business Communications Company, Inc. (Publisher)
This digital document is an article from Nanoparticle News, published by Business Communications Company, Inc. on February 1, 2002. The length of the article is 920 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details Title: Nanocapsules target damaged cells. (Biotechnology News).(protect against radiation)(Brief Article) Publication: Nanoparticle News (Magazine/Journal) Date: February 1, 2002 Publisher: Business Communications Company, Inc. Volume: 5 Issue: 1 Page: 1(3)
Article Type: Brief Article
Distributed by Thomson...
|
|
|
Adult stem cells injected into damaged tissue of heart failure patients improved function.: An article from: Transplant News
by Transplant Communications, Inc. (Publisher)
This digital document is an article from Transplant News, published by Transplant Communications, Inc. on June 30, 2004. The length of the article is 407 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details Title: Adult stem cells injected into damaged tissue of heart failure patients improved function. Publication: Transplant News (Newsletter) Date: June 30, 2004 Publisher: Transplant Communications, Inc. Volume: 14 Issue: 12
Distributed by Thompson...
|
|
|
Tapping the potential of adult stem cells: can adult stem cells help regenerate the damaged blood vessels in patients with peripheral vascular ... An article from: Saturday Evening Post
by Patrick Perry (Author)
This digital document is an article from Saturday Evening Post, published by Thomson Gale on November 1, 2005. The length of the article is 1351 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details Title: Tapping the potential of adult stem cells: can adult stem cells help regenerate the damaged blood vessels in patients with peripheral vascular disease?(HEART BEAT: Healthy Heart Report)(Michael Murphy)(Interview) Author: Patrick Perry Publication: Saturday Evening Post (Magazine/Journal) Date: November 1, 2005 Publisher: Thomson Gale Volume: 277 Issue: 6 Page:...
|
![Increased expression of p53 enhances transcription-coupled repair and global genomic repair of a UVC-damaged reporter gene in human cells [An article from: DNA Repair]](http://ecx.images-amazon.com/images/I/51FZ3K9Y7XL._SX120__PC__PE00_.jpg)
|
Increased expression of p53 enhances transcription-coupled repair and global genomic repair of a UVC-damaged reporter gene in human cells [An article from: DNA Repair]
by D. Dregoesc (Author), A.P. Rybak (Author), A.J. Rainbow (Author)
This digital document is a journal article from DNA Repair, published by Elsevier in 2007. The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser.
Description: Ultraviolet (UV) light-induced DNA damage is repaired by nucleotide excision repair, which is divided into two sub-pathways: global genome repair (GGR) and transcription-coupled repair (TCR). While it is well established that the GGR pathway is dependent on the p53 tumour suppressor protein in human cells, both p53-dependent and p53-independent pathways have been reported for TCR. In the present work, we investigated the role of p53 in both GGR and TCR of a UVC-damaged reporter gene in human fibroblasts. We employed a...
|
|
|
Bone marrow cells may help with variety of cardiac treatments: the use of bone marrow stem cells to repair damaged tissue helps the heart grow new ... An article from: Heart Advisor
by Unavailable (Author)
This digital document is an article from Heart Advisor, published by Belvoir Media Group, LLC on September 1, 2009. The length of the article is 687 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.
Citation Details Title: Bone marrow cells may help with variety of cardiac treatments: the use of bone marrow stem cells to repair damaged tissue helps the heart grow new blood vessels.(BREAKTHROUGHS) Author: Unavailable Publication: Heart Advisor (Magazine/Journal) Date: September 1, 2009 Publisher: Belvoir Media Group, LLC Volume: 12 Issue: 9 Page: 3(1)
Distributed by Gale, a part of Cengage...
|

|
Stem Cells: A Very Short Introduction
by Jonathan Slack (Author)
Embryonic stem cells have been hot-button topics in recent years, generating intense public interest as well as much confusion and misinformation. In this Very Short Introduction, leading authority Jonathan Slack offers a clear and informative overview of stem cells--what they are, what scientists do with them, what stem cell therapies are available today, and how they might be used in the future. Slack explains the difference between embryonic stem cells, which exist only in laboratory cultures, and tissue-specific stem cells, which exist in our bodies, and he discusses how embryonic stem cells may be used in the future to treat such illnesses as diabetes, Parkinson's disease, heart disease, spinal trauma, and retinal degeneration. But he stresses that, despite important advances, the...
|

|
The Immortal Life of Henrietta Lacks
by Rebecca Skloot (Author)
Her name was Henrietta Lacks, but scientists know her as HeLa. She was a poor Southern tobacco farmer who worked the same land as her slave ancestors, yet her cells—taken without her knowledge—became one of the most important tools in medicine. The first “immortal” human cells grown in culture, they are still alive today, though she has been dead for more than sixty years. If you could pile all HeLa cells ever grown onto a scale, they’d weigh more than 50 million metric tons—as much as a hundred Empire State Buildings. HeLa cells were vital for developing the polio vaccine; uncovered secrets of cancer, viruses, and the atom bomb’s effects; helped lead to important advances like in vitro fertilization, cloning, and gene mapping; and have been bought and sold by the billions....
|

|
The Cell: A Molecular Approach, Fourth Edition
by Geoffrey M. Cooper (Author), Robert E. Hausman (Author)
The fourth edition of "The Cell" has been thoroughly updated to reflect major advances in the field, including the role of microRNAs in the regulation of gene expression, advances in stem cell biology, as well as Oncogenes and the rational design of new anticancer drugs. While retaining the overall structure and pedagogy that made previous editions so successful, the fourth edition now includes additional chapters on Programmed Cell death and the Maintenance of Adult Tissues. There is also significant new material on topics like Signalling Networks, Cell-Matrix Interactions and Bioinformations to keep "The Cell" fresh, vibrant and perpetually appealing to students.
|

|
Blocked In The USA: The Stem Cell Miracle
by Dr William Rader (Author)
If you thought the time of dramatic evolutionary advancement in medical knowledge was over, brace yourself for the untold story of a doctor who singlehandedly, in the face of disdain from his colleagues and threats from government bureaucrats, made a breakthrough scientific discovery. Dr. Rader discovered how to apply fetal stem cell technology to humans and has eased the suffering and at times saved the lives of more than 1,500 patients with Autism, Epilepsy, Multiple Sclerosis, Stroke, Parkinson's disease, Muscular Dystrophy, and many other diseases since 1995.Dr. Rader, familiar to millions as a respected medical expert on ABC-TV, reveals the astounding truth about the most extensive fetal stem cell trials ever conducted on human patients - mostly so - called "hopeless" cases. Blocked...
|

|
The Cell's Design: How Chemistry Reveals the Creator's Artistry
by Fazal Rana (Author)
Armed with cutting-edge techniques, biochemists have unwittingly uncovered startling molecular features inside the cell that compel only one possible conclusion--a supernatural agent must be responsible for life. Destined to be a landmark apologetic work, The Cell's Design explores the full scientific and theological impact of these discoveries. Instead of focusing on the inability of natural processes to generate life's chemical systems (as nearly all apologetics works do), Fazale Rana makes a positive case for life's supernatural basis by highlighting the many biochemical features that reflect the Creator's hallmark signature. This breakthrough work extends the case for design beyond irreducible complexity. These never-before-discussed evidences for design will evoke awe and...
|